Literature DB >> 7572815

Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. Clinical relevance, hemolytic and serologic characteristics.

J A Jacobs1, H G Pietersen, E E Stobberingh, P B Soeters.   

Abstract

A collection of 518 "Streptococcus milleri" isolates recovered from clinical specimens was identified to the species level according to recently established criteria. Streptococcus anginosus was the most frequently isolated species (59.3%), followed by S constellatus (30.3%) and S intermedius (10.4%). One third (34%) of all isolates were beta-hemolytic. The majority of S anginosus isolates were nonhemolytic, carried Lancefield group F, or were nongroupable. Most of the S constellatus isolates were beta-hemolytic, as well as 16.6% of S intermedius strains. Streptococcus anginosus was recovered more often from the genital and urinary tracts and S constellatus was recovered from the thorax. Streptococcus intermedius was mostly found in the head and neck area, but was also isolated from the abdomen and the skin, bone, and soft tissue. Streptococcus intermedius and nonhemolytic isolates were recovered most often from abscess-related specimens.

Entities:  

Mesh:

Year:  1995        PMID: 7572815     DOI: 10.1093/ajcp/104.5.547

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  32 in total

1.  PCR-Based methods for genotyping viridans group streptococci.

Authors:  S Alam; S R Brailsford; R A Whiley; D Beighton
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Characterization of blood culture isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen.

Authors:  C M Brandt; G Haase; N Schnitzler; R Zbinden; R Lütticken
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

3.  Macrorestriction fingerprinting of "Streptococcus milleri" group bacteria by pulsed-field gel electrophoresis.

Authors:  K L Bartie; M J Wilson; D W Williams; M A Lewis
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.

Authors:  J A Jacobs; G J van Baar; N H London; J H Tjhie; L M Schouls; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius.

Authors:  M G Macey; R A Whiley; L Miller; H Nagamune
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Association between Streptococcus milleri and abscess formation after appendicitis.

Authors:  R H Hardwick; A Taylor; M H Thompson; E Jones; A M Roe
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

7.  Species-level molecular identification of invasive "Streptococcus milleri" group clinical isolates by nucleic acid sequencing in a centralized regional microbiology laboratory.

Authors:  Peter Daley; Deirdre L Church; Daniel B Gregson; Sameer Elsayed
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

8.  Deep neck space abscesses of dental origin: the impact of Streptococcus group Milleri.

Authors:  Andrej Terzic; Paolo Scolozzi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-17       Impact factor: 2.503

9.  Identification and characterization of a novel secreted glycosidase with multiple glycosidase activities in Streptococcus intermedius.

Authors:  Hidenori Imaki; Toshifumi Tomoyasu; Naoki Yamamoto; Chiharu Taue; Sachiko Masuda; Ayuko Takao; Nobuko Maeda; Atsushi Tabata; Robert A Whiley; Hideaki Nagamune
Journal:  J Bacteriol       Date:  2014-05-23       Impact factor: 3.490

10.  Genotyping by amplified fragment length polymorphism analysis reveals persistence and recurrence of infection with Streptococcus anginosus group organisms.

Authors:  Jan A Jacobs; Jeroen H T Tjhie; Monique G J Smeets; Corrie S Schot; Leo M Schouls
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.